Complement Fixation and Mixed Antigen-Antibody Reactions

The complement fixation test (CFT) operates on the principle that complement proteins are consumed whenever an immune complex forms. The test requires five components: the test antigen (or unknown extract), a known antiserum, a measured amount of complement (usually fresh guinea pig serum, which is rich in complement but free of species-specific antibodies against the test antigen), sensitised indicator cells, and a buffer for dilutions. The steps proceed in two distinct stages, separated by an incubation period.

In stage one, the test extract is combined with the antiserum and a calibrated volume of complement, then incubated at 37 degrees Celsius for 30 to 60 minutes. If the antigen in the extract matches the antibody in the antiserum, immune complexes form and activate the classical complement pathway, consuming the complement. If there is no match, complement remains free. In stage two, sensitised sheep red blood cells are added. Free complement lyses these cells (haemolysis, a clear red solution). Fixed complement cannot lyse them, and the cells settle as a visible pellet. The reading is therefore: intact pellet equals positive reaction, haemolysis equals negative reaction. The logic is inverted compared with most diagnostic tests, which is a common source of confusion for new practitioners.

The test must be standardised before each run. The complement dose is titrated to determine the minimum amount that completely lyses the indicator cells in the absence of any antigen-antibody reaction (100 percent haemolytic complement, or 1 CH100). The working dose used in the test is typically two CH100 units, providing a small excess that ensures complete lysis in negative reactions but remains within the capacity of positive reactions to fully fix. If too little complement is used, even weak reactions appear positive; if too much is used, even strong reactions fail to fix all of it and appear falsely negative.

The forensic application of complement fixation rests on species specificity: an antiserum raised against the serum proteins of one species will, ideally, react only with that species. To produce a working anti-human antiserum, a rabbit is immunised with repeated injections of human serum. The rabbit mounts an immune response and its serum collects antibodies directed against human serum proteins, particularly albumin and globulins. This antiserum is then used as the known antibody in the complement fixation test.

When a bloodstain of unknown origin is submitted to the laboratory, the analyst prepares an aqueous extract of the dried stain. This extract is the test antigen. It is combined with the anti-human antiserum and complement. If the stain is human, the human proteins in the extract react with the anti-human antibodies, fix complement, and the indicator cells remain intact: a positive result confirming human origin. If the stain is animal, the human-specific antibodies do not bind the animal proteins, complement remains free, and the indicator cells lyse: a negative result.

Species identification by complement fixation was used extensively in forensic laboratories in the United Kingdom, continental Europe, and South Asia through much of the twentieth century. The technique was sensitive enough to work on dried, aged stains and required only microgram quantities of protein. The Ouchterlony double diffusion test and the precipitin ring test were often run in parallel as corroborating tests, since both rely on the same antigen-antibody specificity principle but produce visible precipitin bands rather than using the complement cascade as an indicator.

No antiserum is perfectly monospecific. Proteins from different species share conserved regions because they evolved from common ancestral proteins. Human serum albumin and great ape albumins are highly similar in primary sequence, sharing more than 95 percent of amino acid residues with chimpanzee albumin. An anti-human antiserum raised in a rabbit will contain antibodies against many epitopes on human albumin, including those shared with apes. When such an antiserum is tested against a chimpanzee blood extract, it will react, and the complement fixation result will appear positive for human.

Cross-reactivity is not random. It follows phylogenetic distance: a human antiserum cross-reacts more strongly with primate blood than with bovine blood, and more strongly with bovine blood than with avian blood. This graduated cross-reactivity was itself exploited as an early tool for inferring evolutionary relationships, a technique developed by George Nuttall in the early 1900s. In forensic casework, however, a cross-reaction between human antiserum and non-human primate blood is a risk in any case where the suspect animal contact is plausible.

Two practical strategies reduce the impact of cross-reactivity. First, the antiserum can be absorbed by incubating it with the cross-reacting species' antigens before use, which removes the cross-reactive antibodies and leaves only the species-specific ones. Second, the extract can be tested against a panel of antisera covering the most likely alternative species in the geographic and case context, and reaction strengths compared. A true human stain will give a strong reaction with anti-human antiserum and little or no reaction with anti-dog, anti-cat, or anti-bovine antisera. A cross-reacting primate stain may give moderate reactions with multiple primate antisera, which itself is informative.

The prozone effect was first described in the context of syphilis serology, where undiluted sera from some patients gave negative results in the Wassermann complement fixation test while diluted sera from the same patients gave strong positives. The mechanism is now well understood: at very high antibody concentrations, each antibody molecule occupies antigen binding sites independently rather than bridging two antigen molecules. Lattice formation, the three-dimensional network of antigen-antibody cross-links that makes precipitation and agglutination visible and that produces the large immune complexes needed to efficiently fix complement, cannot form when every antigen site is blocked by monovalent antibody binding.

In complement fixation specifically, the prozone effect means that no immune complex large enough to effectively activate complement forms, so complement is not fixed, and the indicator cells lyse. The result reads as negative even though both the antigen and the specific antibody are present. The risk in casework is that a strongly positive sample might be read as negative if the antiserum is used at too high a concentration.

Detection and management of the prozone effect requires serial dilution. The antiserum is tested at several dilutions, typically a two-fold dilution series from 1:2 to 1:256 or beyond. If the extract produces a negative result at low dilution but a positive result at intermediate dilution, the prozone effect is confirmed. The titre, the highest dilution that still gives a positive result, is then reported rather than a simple positive or negative. This practice is standard in quantitative serology and should be applied in any forensic serological protocol involving complement fixation or precipitation reactions.

The postzone effect is the mirror image of the prozone effect and arises when antigen is present at very high concentration relative to antibody. Each antibody molecule has two antigen-binding sites (Fab regions). At antigen excess, both sites on each antibody molecule bind separate antigen molecules. The antibody cannot bridge two antigen molecules because both its arms are already occupied. Again, no lattice forms, no efficient immune complex activates complement, and the result reads as false negative.

In forensic practice, postzone is less commonly encountered than prozone because bloodstain extracts are often dilute rather than concentrated. However, fresh stains or large stain areas dissolved in a small volume of buffer can produce antigen concentrations high enough to trigger postzone effects. Samples from body cavities (pooled blood, fresh serum) are particularly susceptible. The practical management strategy is the same as for prozone: serial dilution of the extract (antigen side) rather than the antiserum. Testing a sample undiluted and at 1:2, 1:4, 1:8, and 1:16 dilutions, and observing the pattern, will reveal a postzone effect as a reaction that appears only at intermediate or higher dilutions of the extract.

The zone of equivalence, the antibody-to-antigen ratio at which lattice formation is optimal and reaction is strongest, sits between the prozone and postzone extremes. The complement fixation test is most reliable when both antiserum and extract are at concentrations near this equivalence zone. Standardisation of antiserum titres and routine dilution of concentrated extracts before testing are the principal controls against both false-negative phenomena.

Complement fixation has significant practical drawbacks that have led to its displacement by immunoassay formats in most contemporary forensic laboratories. Complement is labile: it deteriorates at room temperature and must be stored frozen and titrated fresh for each run. Guinea pig serum is the traditional complement source, and inter-batch variability requires careful standardisation. The test requires living, functional indicator cells, which must also be fresh. The combination of these requirements makes the CFT demanding to set up and quality-control compared with enzyme-linked immunosorbent assay (ELISA), which uses stable, shelf-stable reagents and a colorimetric endpoint readable on a plate reader.

ELISA platforms for species identification use species-specific antibodies conjugated to enzymes such as horseradish peroxidase or alkaline phosphatase. The enzyme converts a colourless substrate to a coloured product, and the absorbance reading is proportional to the amount of specific antigen present. Modern lateral-flow immunoassay strips offer species identification or body-fluid identification in minutes with no laboratory infrastructure. These are discussed in detail under ELISA Principles and Formats in this subject.

Despite its displacement from routine use, complement fixation remains conceptually important in forensic serology training for three reasons. First, its logic illustrates the principles of immune complex formation and complement activation that underlie all complement-based diagnostic methods still in clinical use. Second, historical case reports in the forensic literature, including landmark twentieth-century cases in the United Kingdom and India that helped establish the evidential value of serological blood typing, were based on complement fixation results. Understanding the technique is necessary to evaluate those historical conclusions critically. Third, the false-negative phenomena of prozone and postzone, first characterised in the context of complement fixation tests, apply equally to all precipitation-based and agglutination-based serological tests and to ELISA at extreme concentration ratios.